ArticleThe Australasian journal of dermatology2022

Secukinumab treatment demonstrated high drug survival and sustained effectiveness in patients with severe chronic plaque psoriasis: 21-month analysis in Australian routine clinical practice (SUSTAIN study).

Peter Foley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.